NCI - Grant Policies

Grant Policies and Guidelines

NCI and NIH Grant Submission and Review Policies
Allowable Increase in Requested Direct Costs of Renewal (Type 2) R01, U01, and P01 Applications Change in Allowable Requested Budget Levels of Renewal Applications; NOT-CA-08-026 Frequently Asked Questions on Allowable Increase in Direct Costs for Renewal (Type 2) R01, U01, and P01 Applications Appeals of NIH Initial Peer Review; NOT-OD-11-064 Resubmission of Applications with Pending Appeals of NIH Initial Peer Review Acceptance for Review of Unsolicited Applications that Request $500,000 or More in Direct Costs; NOT-OD-02-004 NCI Policy on Unsolicited R01 Applications that Request $700,000 Direct Costs or More New and Early Stage Investigator Policies NIH Policy on Late Submission of Grant Applications; NOT-OD-15-039 Update to the NIH/AHRQ/NIOSH Policy on Post-Submission Materials; NOT-OD-19-083 NIH Policy Pertaining to Grants to Foreign Institutions, International Organizations and Domestic Grants with Foreign Components; NOT-OD-09-010 Resubmissions of NIH Applications NIH/AHRQ Application Submission/Resubmission Policy; NOT-OD-18-197 Frequently Asked Questions on Resubmission of NIH Applications Updated Guidance on Salary Limitation for Grants and Cooperative Agreements Salary Cap Summary (FY 1990 - Present) NCI Select Awards Pay Policy NCI Interim C.R. Funding Policy for RPG Awards FY 2025 NCI Interim C.R. Funding Policy for RPG Awards FY 2025 (PDF version) Guidance documents for Fs, Ks, Ts, R15s and S10s

NCI and NIH Grant Submission and Review Policies

Allowable Increase in Requested Direct Costs of Renewal (Type 2) R01, U01, and P01 Applications

Resubmissions of NIH Applications

Salary Cap Summary (FY 1990 - Present) NCI Select Awards Pay Policy New Image

Clinical Research/Human Subjects Policies and Guidelines
Research Involving Human Subjects Human Subjects Policies and Guidance Human Subjects Protections Training Research Using Human Specimens, Cell Lines, or Data NIH Policies and NCI Guidance on Data and Safety Monitoring of Clinical Trials NIH Inclusion Policies and Procedures Inclusion of Women and Minorities in Clinical Research Inclusion of Children Policy Implementation Page Legal Requirements Regarding the Acquisition and Use of Human Fetal Tissue for Research Purposes; NIH-OD-15-143 Clinical Trials Reporting Program Institutional Review Board (IRB) Review Guidance on Reporting Adverse Events to IRBs for NIH-Supported Multicenter Clinical Trials; NOT-OD-99-107 Revised Policy for IRB Review of Human Subjects Protocols in Grant Applications

Clinical Research/Human Subjects Policies and Guidelines

NIH Inclusion Policies and Procedures

Institutional Review Board (IRB) Review

NIH Grant Policies
NIH Grants Policy Statement (Dec 2019) NIH Financial Conflict of Interest Intellectual Property Policy NCI/NIH Policies On Sharing Data And Resources NIH Data Sharing Policy NCI Clinical Trial Access Policy Genome Data Commons Model Organism Sharing Policy NIH Public Access Policy